Safety and Precautions
Researchers at the Bluestone Center for Clinical Research have responsibilities for honesty and integrity on all phases of research process. All participants at the Bluestone Center for Clinical Research must undergo an Informed Consent procedure, during which they are informed of their rights and obligations, potential side effects and other study details.
An Institutional Review Board (IRB) from New York University reviews a protocol that outlines the study and provides explicit details of any known potential side effects. The IRB is comprised of a group of doctors, pharmacists and other community members whose primary objective is to ensure the safety of all participants.
At the Bluestone Center for Clinical Research we have a commitment to protect the rights and dignity of our research patients or normal research subjects according the federal regulations ICH and the Guidelines of Good Clinical Practice.
|
|
